Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dirko Hercher"'
Autor:
Martin Boegemann, Sara Khaksar, Guillaume Bera, Alison Birtle, Catherine Dopchie, Louis-Marie Dourthe, Els Everaert, Martin Hatzinger, Dirko Hercher, Werner Hilgers, Geoffrey Matus, Laura Garcia Alvarez, Laurent Antoni, Martin Lukac, Geneviève Pissart, Paul Robinson, Tony Elliott
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background With the recent introduction of novel treatment options, real-world data from patients with metastatic castration-resistant prostate cancer (mCRPC) are required to better understand the impact on routine clinical practice. This st
Externí odkaz:
https://doaj.org/article/bcb68afe464843cda635014d0327f858
Autor:
Els Everaert, M Lukac, Louis-Marie Dourthe, Werner Hilgers, Catherine Dopchie, Dirko Hercher, Geneviève Pissart, Guillaume Bera, Martin Hatzinger, Alison Birtle, Laurent Antoni, Geoffrey Matus, Laura Garcia Alvarez, Paul Robinson, Martin Boegemann, S. Khaksar, Tony Elliott
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)
BMC Cancer
BMC Cancer
Background With the recent introduction of novel treatment options, real-world data from patients with metastatic castration-resistant prostate cancer (mCRPC) are required to better understand the impact on routine clinical practice. This study prima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ca290cdbee899fe078424091f2e323e
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/49072
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/49072
Autor:
D. Sheehan, M Lukac, Laura Garcia Alvarez, Dirko Hercher, Geoffrey Matus, Martin Kluska, Martin Hatzinger, Martin Boegemann, Alison Birtle, Laurent Antoni, Els Everaert, Geneviève Pissart, Lu Zou, Catherine Dopchie, L Dearden
Publikováno v:
Journal of Clinical Oncology. 35:239-239
239 Background: In the COU-AA-302 trial, abiraterone acetate plus prednisone (AAP) resulted in extension of radiographic progression-free survival (rPFS) and overall survival in chemotherapy-naïve mCRPC patients compared to prednisone alone. However
Publikováno v:
European Urology Supplements. 1:116